from 4 sites: wound surface (wound swab), deepest granulation tissue of the wound (tissue culture), end of the suction tube connected to sealed film, and a portion of polyurethane foam sponge surfacing on the wound. The primary outcomes of interest were bioburden reduction and rate of bacterial growth in the 2 groups, which were evaluated according to "rate of culture positivity" each week. Another important measure was the identification and transition of 4 specific bacterial species that are most commonly encountered in clinical settings, Staphylococcus aureus, methicillin-resistant S. aureus (MRSA), Pseudomonas, and Acinetobacter species. Ultimately, 66 wounds in 66 patients were analyzed by this study. The mean duration of NPWT application was 29.9 ± 10.7 days. Of the 66 wounds, 31 wounds were allocated to the conventional NPWT group (31 patients: 23 men and 8 women) and 35 wounds to the silver NPWT group (35 patients: 29 men and 6 women). In the conventional NPWT group, the mean age was 48.5 years and the mean wound size was 260 ± 563 cm 2 . The mean duration of NPWT application was 37.6 ± 7.6 days. In the silver NPWT group, the mean age was 46.5 years and the mean wound size was 233 ± 346 cm 2 . Throughout the study period, no significant complications or adverse events were observed. For MRSA, the silver-impregnated group showed a significant reduction with culture positivity rate on wound surface (at second week, P = 0.010; at third week, P = 0.031; and at final week, P = 0.048) and tissue (at second week, P = 0.030; at third week, P = 0.058; and at final week, 0.076-marginal borderline at third and final week). The MRSA-positive rate in the silver group showed a steady decline over time, with statistical significance. In addition, the MRSA colonization rate in the silver group was lower than in the conventional NPWT group in all locations, with statistically significant differences in wound surface and tissue culture. This randomized study has indicated that silver-impregnated NPWT is more effective for bacterial clearance, especially for MRSA, than conventional NPWT.
BACKGROUND: Free fasciocutaneous flap is used for soft tissue reconstruction, often in patient with peripheral arterial disease. The purpose of this study was to determine whether reconstructive outcomes and healing time were affected by peripheral arterial disease in flap reconstruction harvested from revascularized extremities.
METHODS:
We reviewed 97 consecutive cases of fasciocutaneous flap harvest for microsurgical lower extremity reconstruction with >1 year of follow-up. The cases were divided into 2 groups; one group with flaps harvested from lower extremity with angiographically confirmed peripheral arterial disease and the other group with healthy arterial system. Clinical data including patient demographics, risk factors, details of reconstruction, flap outcomes, and completion of wound healing were collected. Multiple logistic regression model adjusted using inverse probability weighting was computed to determine the association between peripheral arterial disease and the outcomes of harvested flaps.
RESULTS:
Mean follow-up was 26 months. Flap harvests from revascularized extremities were performed for 27 cases and from nondiseased limbs for 70 cases. Fifty-four cases out of 97 cases developed flap-related complications, 8 cases of them were vascular compromise at immediate postoperative phase. One case of total flap necrosis developed in each group. The most common complication was partial flap necrosis, which required additional skin graft procedure. The presence of peripheral arterial disease was not associated with increased flap complication in nonadjusted statistical analysis. Donor site complication was not also significantly affected. However, complete healing of surgical wound was significantly delayed in diseased limb. Similar result was obtained after propensity score-adjusted analysis.
CONCLUSION:
Although peripheral arterial occlusive disease is thought to influence wound healing significantly, the authors found no difference in reconstructive outcomes of harvested flap from between diseased and nondiseased limb. Using free fasciocutaneous flap after revascularization would presumably be a safe and effective reconstructive option for complex wounds.
